Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction

American Journal of Hematology
Sitki ErgulAdviye Ergul

Abstract

While systemic plasma endothelin-1 (ET-1) levels are increased during acute crisis in sickle cell disease, the relative levels of potent vasoactive factors that contribute to the regulation of vascular function, such as ET-1, NO, and cell-free hemoglobin, during the course of periodic vaso-occlusive episodes remain unclear. Moreover, whether and to what extent sickling-induced release of ET-1 alters vascular tone is not completely understood. To investigate the sequential changes in circulating vasoactive factors, we measured plasma ET-1, NO metabolites (NOx), and cell-free hemoglobin (Hb) before (steady-state), during (crisis), and after a vaso-occlusive (post-crisis) episode. Steady-state ET-1 levels (fmol/mL) increased from 2.3 +/- 0.4 to 11.0 +/- 1.4 and 4.2 +/- 1.0 during crisis and post-crisis periods, respectively. There was no significant difference in plasma NOx levels. Cell-free Hb levels were significantly higher in sickle cell patients in all phases as compared to the control group, and especially during crisis cell-free Hb levels were elevated by 4-fold (209,000 +/- 31,000 vs. 46,000 +/- 5,300 ng/mL in steady-state). Conditioned medium from human pulmonary artery endothelial cells exposed to sickled erythrocytes pr...Continue Reading

References

Mar 1, 1994·American Journal of Respiratory Cell and Molecular Biology·M K GlassbergD Puett
Jul 1, 1994·British Journal of Haematology·G R SerjeantP W Thomas
Mar 1, 1996·Blood Reviews·D K KaulR L Nagel
Jul 1, 1997·American Journal of Respiratory and Critical Care Medicine·S I HammermanH W Farber
Sep 11, 1997·The New England Journal of Medicine·H F Bunn
Oct 30, 1998·Journal of Hypertension·W G Haynes, D J Webb
Aug 25, 1999·Proceedings of the Society for Experimental Biology and Medicine·M Kirchengast, K Münter
Oct 12, 1999·The American Journal of Physiology·A RiveraC Brugnara
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·M T GladwinR O Cannon
Jun 20, 2001·American Journal of Hypertension·E L Schiffrin
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·M AslanB A Freeman
Nov 12, 2002·Nature Medicine·Christopher D ReiterMark T Gladwin
May 2, 2003·Nature Medicine·Mark T GladwinAlan N Schechter

❮ Previous
Next ❯

Citations

Nov 6, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Dhananjay K KaulXiaoqin Zhang
Feb 11, 2015·Global Heart·Suman Gidwani, Ajith Nair
Mar 5, 2014·Hematology/oncology Clinics of North America·Carolyn C Hoppe
Nov 26, 2013·Clinics in Chest Medicine·Roberto F Machado, Harrison W Farber
Mar 18, 2011·Kidney International·Andrew M SiedleckiAnthony J Muslin
Jul 4, 2012·Heart Failure Clinics·Dana McGlothlin
Jul 8, 2009·Clinical Biochemistry·Nicola Conran, Fernando F Costa
Jun 3, 2008·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·J-P Cartron, J Elion
Jun 23, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Ilknur KozanogluMahmut Kural
Jun 8, 2007·The Journal of Pain : Official Journal of the American Pain Society·Alvin D McKelvySarah M Sweitzer
Aug 2, 2006·Clinics in Chest Medicine·Casey W Melton, Johnson Haynes
Mar 13, 2012·British Journal of Haematology·Vanessa BourgeauxCyril Martin
Mar 29, 2013·Expert Opinion on Pharmacotherapy·Payal C Desai, Kenneth I Ataga
Apr 27, 2017·Journal of the American Society of Nephrology : JASN·Karl A Nath, Zvonimir S Katusic
Nov 13, 2015·British Journal of Pharmacology·J Brett HeimlichDavid M Pollock
Aug 22, 2017·Blood Reviews·Vijay K KalraStanley M Tahara
Apr 18, 2019·Neuroscience Letters·Megan L Uhelski, Donald A Simone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Aslihan TurhanPaul S Frenette
Lancet
Marie J Stuart, R L Nagel
© 2022 Meta ULC. All rights reserved